Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Shares Issued (2022 - 2025)

Coeptis Therapeutics Holdings (COEP) has 4 years of Shares Issued data on record, last reported at $650.0 in Q3 2025.

  • For Q3 2025, Shares Issued changed N/A year-over-year to $650.0; the TTM value through Sep 2025 reached -$399350.0, down 157.05%, while the annual FY2024 figure was $100000.0, 50.0% down from the prior year.
  • Shares Issued reached $650.0 in Q3 2025 per COEP's latest filing, up from -$400.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $1.3 million in Q3 2022 and bottomed at -$3.3 million in Q4 2022.
  • Average Shares Issued over 4 years is $36422.7, with a median of $100000.0 recorded in 2023.
  • Peak YoY movement for Shares Issued: skyrocketed 106.11% in 2023, then tumbled 300.0% in 2024.
  • A 4-year view of Shares Issued shows it stood at -$3.3 million in 2022, then soared by 106.11% to $200000.0 in 2023, then crashed by 300.0% to -$400000.0 in 2024, then skyrocketed by 100.16% to $650.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $650.0 in Q3 2025, -$400.0 in Q2 2025, and $400.0 in Q1 2025.